Final results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1).

Abstract

4053Background: Concurrent chemoradiotherapy (CCR) with cisplatin plus 5-Fu (PF) regimen is a standard modality for locally advanced esophageal squamous cell carcinoma (ESCC) patients. This trial a...